Affymax Inc Com (NASDAQOTH:AFFY)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.

Recs

0
Player Avatar ravens9111 (53.37) Submitted: 2/25/2013 8:22:49 AM : Outperform Start Price: $2.49 AFFY Score: -62.11

Woah down 83% on the news this morning. Although this is VERY dangerous, I am going in and looking for a bounce.

Featured Broker Partners


Advertisement